These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7808093)

  • 1. The endocrine response to critical illness.
    Rolih CA; Ober KP
    Med Clin North Am; 1995 Jan; 79(1):211-24. PubMed ID: 7808093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine response to exercise.
    Terjung R
    Exerc Sport Sci Rev; 1979; 7():153-80. PubMed ID: 399464
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine problems in critically ill children: an overview.
    Trimarchi T
    AACN Clin Issues; 2006; 17(1):66-78. PubMed ID: 16462411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine manifestations of critical illness in the child.
    Weise K; Zaritsky A
    Pediatr Clin North Am; 1987 Feb; 34(1):119-30. PubMed ID: 3543820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The syndromes of primary hormone resistance.
    Verhoeven GF; Wilson JD
    Metabolism; 1979 Mar; 28(3):253-89. PubMed ID: 216888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and endocrine disease.
    Kokkoris P; Pi-Sunyer FX
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):895-914. PubMed ID: 14711067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophyseal growth hormone. II. Interaction with other hormones.
    Saeed-uz-Zafar M; Mellinger RC; Morrow LB
    Henry Ford Hosp Med J; 1970; 18(3):165-78. PubMed ID: 4318528
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormones in the critically ill patient: to intervene or not to intervene?
    Ligtenberg JJ; Girbes AR; Beentjes JA; Tulleken JE; van der Werf TS; Zijlstra JG
    Intensive Care Med; 2001 Oct; 27(10):1567-77. PubMed ID: 11685296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endocrine disorders associated with impaired glucose tolerance].
    Ogino Y; Toriumi M; Tanaka K
    Nihon Rinsho; 1996 Oct; 54(10):2667-71. PubMed ID: 8914425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine evaluation of patients with critical illness.
    Van den Berghe G
    Endocrinol Metab Clin North Am; 2003 Jun; 32(2):385-410. PubMed ID: 12800538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and lipoprotein metabolism.
    Kissebah AH; Schectman G
    Baillieres Clin Endocrinol Metab; 1987 Aug; 1(3):699-725. PubMed ID: 3330425
    [No Abstract]   [Full Text] [Related]  

  • 12. CIRMI-a new term for a concept worthy of further exploration: a narrative review.
    Nethathe GD; Lipman J; Anderson R; Feldman C
    Ann Transl Med; 2022 Jun; 10(11):646. PubMed ID: 35813323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine factors in the neonatal adaptation.
    Sulyok E
    Acta Physiol Hung; 1989; 74(3-4):329-39. PubMed ID: 2701149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal control of muscle growth.
    Florini JR
    Muscle Nerve; 1987 Sep; 10(7):577-98. PubMed ID: 3309650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine problems in the chronically critically ill patient.
    Vasa FR; Molitch ME
    Clin Chest Med; 2001 Mar; 22(1):193-208. PubMed ID: 11315456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system].
    Rom-Bugoslavskaia ES; Komarova IV
    Probl Endokrinol (Mosk); 1986; 32(2):13-6. PubMed ID: 2424003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrine disorders in diabetes mellitus].
    Okazaki R; Toriumi M; Tanaka K
    Nihon Rinsho; 1997 Oct; 55 Suppl():667-72. PubMed ID: 9392179
    [No Abstract]   [Full Text] [Related]  

  • 19. Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis.
    Hempenius LM; Van Dam PS; Marx JJ; Koppeschaar HP
    J Endocrinol Invest; 1999 May; 22(5):369-76. PubMed ID: 10401711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine factors in dental development].
    Job JC; Mugnier A
    Rev Fr Odontostomatol; 1969 May; 16(5):625-34. PubMed ID: 5257247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.